DALES NATALIE enters ODYSSEY THERAPEUTICS, INC. with 36.88K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/8/2026ACC: 0001193125-26-212865
Officer· See Remarks
Since May 2026
36.88K
Baseline shares
100% direct
36.88K
Direct ownership
1 position
45.48K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned36.88K
Total
36.88K direct36.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 36.88K | Direct |
| Total | 36.88K | 36.88K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
40.66K
Shares owned
N/A
Exercise price
4.18
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
4.83K
Shares owned
N/A
Exercise price
3.98
Expiration
—
Exercise window
—
Total
Underlying
45.48K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 4.18 | — | — | 40.66K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.98 | — | — | 4.83K | N/A |
| Total | 45.48K | 0.00 | ||||